Ring 1
Ring 2
Ring 3
Ring 4

Vor Biopharma

Financing Rounds

  • Series B
  • Public
Round Led by Symbiosis
Round Led by Symbiosis

Vor Biopharma is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant.

vor View Website

Modality

  • Cell Therapy

Indication

  • Oncology

Development Status

  • Phase 1